Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Gill

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Therapeutics|July 16, 2003
A review of rivastigmine: a reversible cholinesterase inhibitorBradley R Williams, Arlette Nazarians, Mark A Gill
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 6, 2004
Stability of advanced life support drugs in the fieldMark A Gill, Alice Z Kislik, Lana Gore, et al.
Current Opinion in Pulmonary Medicine|October 24, 2002
Potential role of macrolide antibiotics in the management of cystic fibrosis lung diseaseThao Nguyen, Stan G Louie, Paul M Beringer, et al.
Therapeutic Drug Monitoring|November 27, 2002
A wide interindividual variability of urinary 6beta-hydroxycortisol to free cortisol in 487 healthy Japanese subjects in near basal conditionKazuhiro Inagaki, Masami Inagaki, Tomomi Kataoka, et al.
Clinical Pharmacokinetics|February 12, 2004
Pharmacokinetics of Ibuprofen in children with cystic fibrosisEmily E Han, Paul M Beringer, Stan G Louie, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Stability and antibacterial activity of cefepime during continuous infusionPål F Sprauten, Paul M Beringer, Stan G Louie, et al.
The Journal of Trauma|January 30, 2004
Imipenem levels are not predictable in the critically ill patientHoward Belzberg, Jay Zhu, Edward E Cornwell, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Therapeutics|July 16, 2003
A review of rivastigmine: a reversible cholinesterase inhibitorBradley R Williams, Arlette Nazarians, Mark A Gill
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 6, 2004
Stability of advanced life support drugs in the fieldMark A Gill, Alice Z Kislik, Lana Gore, et al.
Current Opinion in Pulmonary Medicine|October 24, 2002
Potential role of macrolide antibiotics in the management of cystic fibrosis lung diseaseThao Nguyen, Stan G Louie, Paul M Beringer, et al.
Therapeutic Drug Monitoring|November 27, 2002
A wide interindividual variability of urinary 6beta-hydroxycortisol to free cortisol in 487 healthy Japanese subjects in near basal conditionKazuhiro Inagaki, Masami Inagaki, Tomomi Kataoka, et al.
Clinical Pharmacokinetics|February 12, 2004
Pharmacokinetics of Ibuprofen in children with cystic fibrosisEmily E Han, Paul M Beringer, Stan G Louie, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Stability and antibacterial activity of cefepime during continuous infusionPål F Sprauten, Paul M Beringer, Stan G Louie, et al.
The Journal of Trauma|January 30, 2004
Imipenem levels are not predictable in the critically ill patientHoward Belzberg, Jay Zhu, Edward E Cornwell, et al.
Pageof 1